Treatment of severe systemic lupus erythematosus with high-dose chemotherapy haemopoietic stem-cell transplantation: A phase I study

Lancet

Volumn 356, Issue 9231, 2000, Pages 701-707

  Traynor, Ann E ^a,b   Schroeder, James ^a   Rosa, Robert M ^a   Cheng, Dong ^a   Stefka, Jakub ^a   Mujais, Salim ^a   Baker, Steven ^a   Burt, Richard K ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; METHYLPREDNISOLONE; PREDNISONE; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ACTIVITY; FOLLOW UP; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE COUNT; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE COUNT; TREATMENT OUTCOME;

EID: 0034718372     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)02627-1     Document Type: Article

References (28)

1. Therapy of lupus nephritis: Controlled trial of prednisone and cytotoxic drugs
2. Why do patients with lupus nephritis die?
3. Mortality studies in systemic lupus erythematosus: Results from a single center, II - Predictor variables for mortality
4. Evolving spectrum of mortality and morbidity in SLE
5. Morbidity and mortality in systemic lupus erythematosus during a 5-year period: A multicentre prospective study of 1,000 patients - European Working Party on Systemic Lupus Erythematosus
6. Participation of the CD69 antigen in the T-cell activation process of patients with systemic lupus erythematosus
7. Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10: Interferon-gamma-secreting cells in the peripheral blood
8. Increased spontaneous IL-10 production and decreased mitogen induced IFN-γ and TNF α production in untreated patients with SLE: Role of CD 8+ T cell
9. The role of transforming growth factor-b in the generation of suppression: An interaction between CD8+ T and NK. Cells
10. Single step method of RNA isolation by acid guanidium thiocyanate chloroform extraction
11. Treatment of systemic and organ specific auto-immune disease in mice by allogeneic bone marrrow transplantation
12. Genetic dissection of lupus nephritis in murine models of SLE
13. Effective treatment of autoimmune disease and progressive renal disease by mixed bone-marrow transplantation that establishes a stable mixed chimerism in BXSB recipient mice
14. Prevention of development of autoimmune disease in BXSB mice by mixed bone marrow transplantation
15. Immunomodulation of autoimmunity in MRL/lpr mice with syngeneic bone marrow transplantation (SBMT)
16. Monozygotic twins discordant for systemic lupus erythematosus
17. A revised estimated of twin concordance in systemic lupus erythematosus
18. Immunoablative high dose cyclophosphamide without stem cell rescue for refractory autoimmune disease
19. Hematopoietic stem-cell transplantation for systemic lupus erythematosus
20. Treatment of autoimmune disease by intense immunosuppressive conditioning and autologous hematopoietic stem cell transplantation
21. Autologous marrow stem cell transplantation for severe systemic lupus erythematosus of long duration
22. Control of severe systemic lupus erythematosus after high dose immunosuppressive therapy and transplantation of CD34+ purified autologous stem cells from peripheral blood
23. Autologous peripheral blood stem and progenitor (CD34+) cell transplantation for systemic lupus erythematosus complicated by Evans syndrome
24. Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells
25. Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus
26. CD69 to CD3 ratio of peripheral blood mononuclear cells as a marker to monitor systemic lupus erythematosus disease activity
27. Impaired delayed hypersensitivity in systemic lupus erythematosus
28. Abnormalities of delayed type hypersensitivity in systemic lupus erythematosus